HK1199889A1 - Relaxin fusion polypeptides and uses thereof - Google Patents
Relaxin fusion polypeptides and uses thereofInfo
- Publication number
- HK1199889A1 HK1199889A1 HK15100367.8A HK15100367A HK1199889A1 HK 1199889 A1 HK1199889 A1 HK 1199889A1 HK 15100367 A HK15100367 A HK 15100367A HK 1199889 A1 HK1199889 A1 HK 1199889A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- fusion polypeptides
- relaxin fusion
- relaxin
- polypeptides
- fusion
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/64—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11172413 | 2011-07-01 | ||
EP11172681 | 2011-07-05 | ||
PCT/EP2012/062665 WO2013004607A1 (en) | 2011-07-01 | 2012-06-29 | Relaxin fusion polypeptides and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1199889A1 true HK1199889A1 (en) | 2015-07-24 |
Family
ID=46489195
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK15100367.8A HK1199889A1 (en) | 2011-07-01 | 2015-01-14 | Relaxin fusion polypeptides and uses thereof |
Country Status (14)
Country | Link |
---|---|
US (1) | US9382305B2 (de) |
EP (1) | EP2726502A1 (de) |
JP (1) | JP2014522641A (de) |
KR (1) | KR20140054009A (de) |
CN (1) | CN103930440A (de) |
AR (1) | AR087020A1 (de) |
AU (1) | AU2012280474A1 (de) |
BR (1) | BR112014000055A2 (de) |
CA (1) | CA2840552A1 (de) |
HK (1) | HK1199889A1 (de) |
MX (1) | MX2014000031A (de) |
RU (1) | RU2014103288A (de) |
WO (1) | WO2013004607A1 (de) |
ZA (1) | ZA201400762B (de) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112014000055A2 (pt) | 2011-07-01 | 2017-06-13 | Bayer Ip Gmbh | polipeptídeos de fusão de relaxina e usos dos mesmos |
AR094147A1 (es) * | 2012-12-27 | 2015-07-15 | Bayer Pharma Aktiengellschaft | Polipeptidos de fusion con actividad de relaxina y sus usos |
US10030067B2 (en) | 2013-03-15 | 2018-07-24 | University Of Florida Research Foundation, Incorporated | Compounds for treating neurodegenerative proteinopathies |
JP6822839B2 (ja) | 2013-09-13 | 2021-01-27 | ザ・スクリップス・リサーチ・インスティテュート | 修飾された治療剤、及びその組成物 |
EP3068891A1 (de) | 2013-11-13 | 2016-09-21 | Aequus Biopharma Inc. | Manipulierte glycoproteine und verwendungen davon |
KR102455171B1 (ko) | 2013-12-18 | 2022-10-14 | 더 스크립스 리서치 인스티튜트 | 변형된 치료제, 스테이플드 펩티드 지질 접합체, 및 이의 조성물 |
CA2952061A1 (en) * | 2014-06-13 | 2015-12-17 | Novartis Ag | Use of serelaxin to reduce gdf-15 |
US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
CN104447982B (zh) * | 2014-09-29 | 2017-08-25 | 深圳市辰瑞尔生物科技有限公司 | 一种人松弛素h2前体及其制备方法和应用 |
US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
CN107847588B (zh) * | 2015-05-20 | 2021-12-28 | 免疫功坊股份有限公司 | 具有靶向部分及效应部分的分子构建体及其应用 |
EP3387019B1 (de) * | 2015-12-09 | 2021-10-20 | The Scripps Research Institute | Relaxin-immunglobulin-fusionsproteine und verfahren zur verwendung |
MX2018010824A (es) * | 2016-03-08 | 2019-05-15 | Maverick Therapeutics Inc | Proteinas de union inducibles y metodos de uso. |
US11753438B2 (en) | 2016-05-11 | 2023-09-12 | Cytiva Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
WO2017194592A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of storing a separation matrix |
US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
US10513537B2 (en) | 2016-05-11 | 2019-12-24 | Ge Healthcare Bioprocess R&D Ab | Separation matrix |
IL263079B2 (en) * | 2016-05-18 | 2024-05-01 | Modernatx Inc | Relaxin-encoding polynucleotides |
US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
CN110225924B (zh) * | 2017-01-25 | 2024-04-02 | 免疫医疗有限公司 | 松弛素融合多肽及其用途 |
CN110637027A (zh) | 2017-02-08 | 2019-12-31 | 百时美施贵宝公司 | 包含药代动力学增强子的修饰的松弛素多肽及其用途 |
WO2018213526A2 (en) | 2017-05-18 | 2018-11-22 | Biocapital Holdings, Llc | Uv-resistant biological devices and extracts and methods for producing and using the same |
JP7268005B2 (ja) | 2017-09-08 | 2023-05-02 | 武田薬品工業株式会社 | 拘束され、条件的に活性化された結合タンパク質 |
CN109879969B (zh) * | 2017-12-06 | 2024-04-09 | 天士力生物医药股份有限公司 | 一种hm-3融合蛋白及其应用 |
WO2019125975A1 (en) | 2017-12-18 | 2019-06-27 | Biocapital Holdings, Llc | Biological devices and methods of use thereof for the detection of amyloid proteins |
SG11202006903WA (en) * | 2018-01-31 | 2020-08-28 | Sanofi Sa | Modified lipidated relaxin b chain peptides and their therapeutic use |
CN112243444A (zh) * | 2018-06-08 | 2021-01-19 | 豪夫迈·罗氏有限公司 | 具有减少的翻译后修饰的肽接头 |
BR112021015832A2 (pt) | 2019-02-12 | 2022-01-18 | Ambrx Inc | Composições que contêm conjugados de anticorpo-agonista de tlr, métodos e usos dos mesmos |
JP2022524338A (ja) | 2019-03-05 | 2022-05-02 | 武田薬品工業株式会社 | 拘束され、条件的に活性化された結合タンパク質 |
AU2020321977C1 (en) | 2019-07-31 | 2024-04-18 | Eli Lilly And Company | Relaxin analogs and methods of using the same |
WO2021226439A2 (en) * | 2020-05-08 | 2021-11-11 | President And Fellows Of Harvard College | Engineered relaxins and methods of use thereof |
JP2023530335A (ja) | 2020-06-17 | 2023-07-14 | メドイミューン・リミテッド | ヘテロ二量体リラキシン融合物及びその使用 |
JP2023538071A (ja) | 2020-08-20 | 2023-09-06 | アンブルックス,インコーポレイテッド | 抗体-tlrアゴニストコンジュゲート、その方法及び使用 |
CA3213805A1 (en) | 2021-04-03 | 2022-10-06 | Feng Tian | Anti-her2 antibody-drug conjugates and uses thereof |
WO2023111112A1 (en) | 2021-12-15 | 2023-06-22 | Medimmune Limited | Treatment using heterodimeric relaxin fusions |
WO2024121362A1 (en) | 2022-12-09 | 2024-06-13 | Astrazeneca Ab | Dosing regimens using heterodimeric relaxin fusions |
Family Cites Families (104)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US4657760A (en) | 1979-03-20 | 1987-04-14 | Ortho Pharmaceutical Corporation | Methods and compositions using monoclonal antibody to human T cells |
US4399216A (en) | 1980-02-25 | 1983-08-16 | The Trustees Of Columbia University | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4634665A (en) | 1980-02-25 | 1987-01-06 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US5179017A (en) | 1980-02-25 | 1993-01-12 | The Trustees Of Columbia University In The City Of New York | Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials |
US4510245A (en) | 1982-11-18 | 1985-04-09 | Chiron Corporation | Adenovirus promoter system |
NZ206534A (en) | 1982-12-13 | 1988-05-30 | Florey Howard Inst | Molecular cloning and characterisation of gene sequence coding for human relaxin |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
EP0154316B1 (de) | 1984-03-06 | 1989-09-13 | Takeda Chemical Industries, Ltd. | Chemisch modifizierte Lymphokine und Verfahren zu ihrer Herstellung |
GB8430252D0 (en) | 1984-11-30 | 1985-01-09 | Beecham Group Plc | Compounds |
US5168062A (en) | 1985-01-30 | 1992-12-01 | University Of Iowa Research Foundation | Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5206344A (en) | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
WO1987000056A1 (en) | 1985-06-26 | 1987-01-15 | Cetus Corporation | Solubilization of proteins for pharmaceutical compositions using polymer conjugation |
US4968615A (en) | 1985-12-18 | 1990-11-06 | Ciba-Geigy Corporation | Deoxyribonucleic acid segment from a virus |
GB8725529D0 (en) | 1987-10-30 | 1987-12-02 | Delta Biotechnology Ltd | Polypeptides |
US4847325A (en) | 1988-01-20 | 1989-07-11 | Cetus Corporation | Conjugation of polymer to colony stimulating factor-1 |
GB8824591D0 (en) | 1988-10-20 | 1988-11-23 | Royal Free Hosp School Med | Fractionation process |
ATE135370T1 (de) | 1988-12-22 | 1996-03-15 | Kirin Amgen Inc | Chemisch modifizierte granulocytenkolonie erregender faktor |
US4902502A (en) | 1989-01-23 | 1990-02-20 | Cetus Corporation | Preparation of a polymer/interleukin-2 conjugate |
EP0470128B2 (de) | 1989-04-19 | 2003-08-13 | Enzon, Inc. | Aktive karbonate von polyalkylenoxyden zur modifizierung von polypeptiden |
US5122614A (en) | 1989-04-19 | 1992-06-16 | Enzon, Inc. | Active carbonates of polyalkylene oxides for modification of polypeptides |
ATE92107T1 (de) | 1989-04-29 | 1993-08-15 | Delta Biotechnology Ltd | N-terminale fragmente von menschliches serumalbumin enthaltenden fusionsproteinen. |
CA2051375C (en) * | 1989-05-04 | 2000-09-12 | Dennis J. Henner | Process and compositions for the isolation of human relaxin |
ES2085297T3 (es) | 1989-05-27 | 1996-06-01 | Sumitomo Pharma | Procedimiento para preparar derivados de poli(etilenglicol) y proteina modificada. |
FR2650598B1 (fr) | 1989-08-03 | 1994-06-03 | Rhone Poulenc Sante | Derives de l'albumine a fonction therapeutique |
US5225212A (en) | 1989-10-20 | 1993-07-06 | Liposome Technology, Inc. | Microreservoir liposome composition and method |
US5219564A (en) | 1990-07-06 | 1993-06-15 | Enzon, Inc. | Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon |
WO1992008790A1 (en) | 1990-11-14 | 1992-05-29 | Cargill, Incorporated | Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins |
US5525491A (en) | 1991-02-27 | 1996-06-11 | Creative Biomolecules, Inc. | Serine-rich peptide linkers |
JPH06506217A (ja) | 1991-03-18 | 1994-07-14 | エンゾン,インコーポレーテッド | ポリペプチドまたはグリコポリペプチドとポリマーとのヒドラジン含有結合体 |
US5595732A (en) | 1991-03-25 | 1997-01-21 | Hoffmann-La Roche Inc. | Polyethylene-protein conjugates |
US5304473A (en) * | 1991-06-11 | 1994-04-19 | Eli Lilly And Company | A-C-B proinsulin, method of manufacturing and using same, and intermediates in insulin production |
US5281698A (en) | 1991-07-23 | 1994-01-25 | Cetus Oncology Corporation | Preparation of an activated polymer ester for protein conjugation |
FR2686901A1 (fr) | 1992-01-31 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides antithrombotiques, leur preparation et compositions pharmaceutiques les contenant. |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
ZA933926B (en) | 1992-06-17 | 1994-01-03 | Amgen Inc | Polyoxymethylene-oxyethylene copolymers in conjuction with blomolecules |
WO1994004193A1 (en) | 1992-08-21 | 1994-03-03 | Enzon, Inc. | Novel attachment of polyalkylene oxides to bio-effecting substances |
US5382657A (en) | 1992-08-26 | 1995-01-17 | Hoffmann-La Roche Inc. | Peg-interferon conjugates |
NZ250375A (en) | 1992-12-09 | 1995-07-26 | Ortho Pharma Corp | Peg hydrazone and peg oxime linkage forming reagents and protein derivatives |
US5298643A (en) | 1992-12-22 | 1994-03-29 | Enzon, Inc. | Aryl imidate activated polyalkylene oxides |
US5349001A (en) | 1993-01-19 | 1994-09-20 | Enzon, Inc. | Cyclic imide thione activated polyalkylene oxides |
US5321095A (en) | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
IL104734A0 (en) | 1993-02-15 | 1993-06-10 | Univ Bar Ilan | Bioactive conjugates of cellulose with amino compounds |
WO1994028024A1 (en) | 1993-06-01 | 1994-12-08 | Enzon, Inc. | Carbohydrate-modified polymer conjugates with erythropoietic activity |
WO1995000162A1 (en) | 1993-06-21 | 1995-01-05 | Enzon, Inc. | Site specific synthesis of conjugated peptides |
GB9317618D0 (en) | 1993-08-24 | 1993-10-06 | Royal Free Hosp School Med | Polymer modifications |
US5643575A (en) | 1993-10-27 | 1997-07-01 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
US5919455A (en) | 1993-10-27 | 1999-07-06 | Enzon, Inc. | Non-antigenic branched polymer conjugates |
DK0730470T3 (da) | 1993-11-10 | 2002-06-03 | Enzon Inc | Forbedrede interferonpolymerkonjugater |
US5951974A (en) | 1993-11-10 | 1999-09-14 | Enzon, Inc. | Interferon polymer conjugates |
US5446090A (en) | 1993-11-12 | 1995-08-29 | Shearwater Polymers, Inc. | Isolatable, water soluble, and hydrolytically stable active sulfones of poly(ethylene glycol) and related polymers for modification of surfaces and molecules |
US5473034A (en) | 1994-03-18 | 1995-12-05 | Hyogo Prefectural Government | Method for producing protein-synthetic polymer conjugate and said conjugate produced thereby |
US5629384A (en) | 1994-05-17 | 1997-05-13 | Consiglio Nazionale Delle Ricerche | Polymers of N-acryloylmorpholine activated at one end and conjugates with bioactive materials and surfaces |
WO1995033490A1 (en) | 1994-06-02 | 1995-12-14 | Enzon, Inc. | Method of solubilizing substantially water insoluble materials |
US5730990A (en) | 1994-06-24 | 1998-03-24 | Enzon, Inc. | Non-antigenic amine derived polymers and polymer conjugates |
US5650234A (en) | 1994-09-09 | 1997-07-22 | Surface Engineering Technologies, Division Of Innerdyne, Inc. | Electrophilic polyethylene oxides for the modification of polysaccharides, polypeptides (proteins) and surfaces |
US5824784A (en) | 1994-10-12 | 1998-10-20 | Amgen Inc. | N-terminally chemically modified protein compositions and methods |
WO1996041813A2 (en) | 1994-11-09 | 1996-12-27 | Offord Robin E | Functionalized polymers for site-specific attachment |
US5738846A (en) | 1994-11-10 | 1998-04-14 | Enzon, Inc. | Interferon polymer conjugates and process for preparing the same |
US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
AU5893696A (en) | 1995-06-07 | 1996-12-30 | Novo Nordisk A/S | Modification of polypeptides |
US5672662A (en) | 1995-07-07 | 1997-09-30 | Shearwater Polymers, Inc. | Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications |
EP0866861B1 (de) | 1995-11-03 | 2004-02-25 | Regeneron Pharmaceuticals, Inc. | Molekulare klonierung und charakterisierung von molekülen, welche verwandt sind mit relaxin und liganden der insulinfamilie |
BR9707003A (pt) | 1996-01-17 | 1999-07-20 | Novo Nordisk As | Composto processos para preparar o mesmo para tratamento ou de prevenção de doenças do sistema endócrino e para a manufatura de medicamento coposção farmacêutica e utilização de um composto |
US5747639A (en) | 1996-03-06 | 1998-05-05 | Amgen Boulder Inc. | Use of hydrophobic interaction chromatography to purify polyethylene glycols |
TW517067B (en) | 1996-05-31 | 2003-01-11 | Hoffmann La Roche | Interferon conjugates |
WO1998005363A2 (en) | 1996-08-02 | 1998-02-12 | Ortho-Mcneil Pharmaceutical, Inc. | Polypeptides having a single covalently bound n-terminal water-soluble polymer |
AU5773798A (en) | 1997-01-29 | 1998-08-18 | Polymasc Pharmaceuticals Plc | Pegylation process |
JP4187277B2 (ja) | 1997-04-30 | 2008-11-26 | エンゾン ファーマシューティカルズ, インコーポレイテッド | グリコシル化し得る抗原結合単鎖タンパク質、それらの生成および使用 |
US6583267B2 (en) | 1997-06-06 | 2003-06-24 | Kyowa Hakko Kogyo Co., Ltd. | Chemically modified polypeptides |
BR9810592A (pt) | 1997-07-16 | 2000-09-12 | Novo Nordisk As | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto |
US5985263A (en) | 1997-12-19 | 1999-11-16 | Enzon, Inc. | Substantially pure histidine-linked protein polymer conjugates |
US5981709A (en) | 1997-12-19 | 1999-11-09 | Enzon, Inc. | α-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
JP4574007B2 (ja) | 1998-04-28 | 2010-11-04 | メルク・セローノ・ソシエテ・アノニム | ポリオール−ifn−ベータ複体 |
DE19834047A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Substituierte Pyrazolderivate |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE19943639A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Dicarbonsäurederivate mit neuartigen pharmazeutischen Eigenschaften |
DE19943634A1 (de) | 1999-09-13 | 2001-04-12 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943635A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE19943636A1 (de) | 1999-09-13 | 2001-03-15 | Bayer Ag | Neuartige Dicarbonsäurederivate mit pharmazeutischen Eigenschaften |
US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
AU784285B2 (en) | 1999-12-24 | 2006-03-02 | Genentech Inc. | Methods and compositions for prolonging elimination half-times of bioactive compounds |
AU2001236886A1 (en) * | 2000-02-09 | 2001-08-20 | Connetics Corporation | Use of relaxin to treat diseases related to vasoconstriction |
CA2399832C (en) | 2000-02-11 | 2011-09-20 | Stephen D. Gillies | Enhancing the circulating half-life of antibody-based fusion proteins |
EP2267026A1 (de) | 2000-04-12 | 2010-12-29 | Human Genome Sciences, Inc. | Albuminfusionsproteine |
AR031176A1 (es) | 2000-11-22 | 2003-09-10 | Bayer Ag | Nuevos derivados de pirazolpiridina sustituidos con piridina |
ES2311560T3 (es) | 2000-12-07 | 2009-02-16 | Eli Lilly And Company | Proteinas de fusion glp-1. |
DE10110749A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Substituierte Aminodicarbonsäurederivate |
DE10110750A1 (de) | 2001-03-07 | 2002-09-12 | Bayer Ag | Neuartige Aminodicarbonsäurederivate mit pharmazeutischen Eigenschaften |
DE10112825A1 (de) | 2001-03-16 | 2002-10-02 | Fresenius Kabi De Gmbh | HESylierung von Wirkstoffen in wässriger Lösung |
DE10207072A1 (de) | 2002-02-20 | 2003-08-28 | Supramol Parenteral Colloids | Stärkederivate, ihre Konjugate und Verfahren zur Herstellung derselben |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
WO2005014655A2 (en) | 2003-08-08 | 2005-02-17 | Fresenius Kabi Deutschland Gmbh | Conjugates of hydroxyalkyl starch and a protein |
ES2390885T3 (es) | 2004-03-11 | 2012-11-19 | Fresenius Kabi Deutschland Gmbh | Conjugados de hidroxialquilalmidón y una proteína |
EP2371856B1 (de) | 2004-11-12 | 2022-05-18 | Bayer HealthCare LLC | Ortsgerichtete Modifizierung von FVIII |
NZ598709A (en) * | 2008-05-16 | 2013-09-27 | Corthera Inc | Treating acute decompensated heart failure with relaxin |
WO2010054699A1 (en) | 2008-11-17 | 2010-05-20 | Affibody Ab | Conjugates of albumin binding domain |
US8389475B2 (en) | 2009-08-10 | 2013-03-05 | The Board Of Trustees Of The Leland Stanford Junior University | Relaxin analogs |
US20110243943A1 (en) * | 2010-04-02 | 2011-10-06 | Athena Discovery, Inc. | Treatment using relaxin-fusion proteins with extended in vivo half-lives |
WO2011130332A1 (en) | 2010-04-12 | 2011-10-20 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
BR112013003522B1 (pt) * | 2010-08-17 | 2021-05-25 | Ambrx, Inc. | polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, seu método de preparação e seu uso, bem como ácido nucleico e célula hospedeira |
BR112014000055A2 (pt) | 2011-07-01 | 2017-06-13 | Bayer Ip Gmbh | polipeptídeos de fusão de relaxina e usos dos mesmos |
BR112014000474A2 (pt) | 2011-07-08 | 2017-02-21 | Bayer Ip Gmbh | proteínas de fusão libertadoras de relaxina e suas utilizações |
-
2012
- 2012-06-29 BR BR112014000055A patent/BR112014000055A2/pt not_active Application Discontinuation
- 2012-06-29 CN CN201280041620.9A patent/CN103930440A/zh active Pending
- 2012-06-29 CA CA2840552A patent/CA2840552A1/en not_active Abandoned
- 2012-06-29 JP JP2014517726A patent/JP2014522641A/ja active Pending
- 2012-06-29 AR ARP120102381A patent/AR087020A1/es active Pending
- 2012-06-29 MX MX2014000031A patent/MX2014000031A/es unknown
- 2012-06-29 AU AU2012280474A patent/AU2012280474A1/en not_active Abandoned
- 2012-06-29 WO PCT/EP2012/062665 patent/WO2013004607A1/en active Application Filing
- 2012-06-29 US US14/130,493 patent/US9382305B2/en not_active Expired - Fee Related
- 2012-06-29 RU RU2014103288/10A patent/RU2014103288A/ru not_active Application Discontinuation
- 2012-06-29 KR KR1020147002543A patent/KR20140054009A/ko not_active Application Discontinuation
- 2012-06-29 EP EP12733454.8A patent/EP2726502A1/de not_active Withdrawn
-
2014
- 2014-01-31 ZA ZA2014/00762A patent/ZA201400762B/en unknown
-
2015
- 2015-01-14 HK HK15100367.8A patent/HK1199889A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN103930440A (zh) | 2014-07-16 |
JP2014522641A (ja) | 2014-09-08 |
AR087020A1 (es) | 2014-02-05 |
ZA201400762B (en) | 2016-02-24 |
AU2012280474A1 (en) | 2014-01-16 |
RU2014103288A (ru) | 2015-08-10 |
KR20140054009A (ko) | 2014-05-08 |
EP2726502A1 (de) | 2014-05-07 |
US20140187491A1 (en) | 2014-07-03 |
CA2840552A1 (en) | 2013-01-10 |
MX2014000031A (es) | 2014-07-09 |
BR112014000055A2 (pt) | 2017-06-13 |
WO2013004607A1 (en) | 2013-01-10 |
US9382305B2 (en) | 2016-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1199889A1 (en) | Relaxin fusion polypeptides and uses thereof | |
HK1258140A1 (zh) | 經修飾鬆弛素多肽及其用途 | |
IL229753A0 (en) | Proteins that release relaxin and their use | |
HK1210790A1 (en) | Modified factor polypeptides and uses thereof | |
EP2877854A4 (de) | Fusionsproteine und verfahren dafür | |
GB201201100D0 (en) | Polypeptides and methods | |
SG10202100341XA (en) | Npp1 fusion proteins | |
EP2711376A4 (de) | Fgfr-fc-fusionsprotein und verwendung davon | |
EP2698386A4 (de) | Fusionsprotein | |
EP2683742A4 (de) | Npp1-fusionsproteine | |
ZA201309679B (en) | Amylin peptides and derivatives and uses thereof | |
EP2930189A4 (de) | Chemokin-cytokin-fusionsprotein und anwendung davon | |
HK1198655A1 (en) | High mast2-affinity polypeptides and uses thereof mast2 | |
EP2657337A4 (de) | Fusionsprotein | |
HK1211042A1 (en) | Inflammation-enabling polypeptides and uses thereof | |
ZA201207425B (en) | Fusion protein | |
EP2614076A4 (de) | Veränderte relaxin-polypeptide | |
ZA201504462B (en) | TGFß-DERIVED POLYPEPTIDES AND USES THEREOF | |
GB201010202D0 (en) | Fusion polypeptides | |
AU2011902389A0 (en) | Modified relaxin polypeptides | |
GB201210303D0 (en) | Polypeptides and methods | |
GB201104152D0 (en) | Fusion Polypeptide | |
GB201007955D0 (en) | Somatosatin fusion proteins | |
GB201204065D0 (en) | Fusion polypeptide | |
GB201114701D0 (en) | Fusion proteins |